Press release
US Transcranial Magnetic Stimulator (TMS) Market Competition by Company, Country, Application/Type & Forecast to 2028 | MAG & More GmbH, MAG & More GmbH
US Transcranial Magnetic Stimulator (TMS) Market
The major factors such as the growing prevalence of neurological disorders, increasing geriatric population and neurological disorders associated with age, and presence of well-established healthcare facilities drive the growth of the transcranial magnetic stimulator (TMS) market. However, the high cost of diagnostic and treatment restricts the market growth.
Company Profiles
• BrainsWay Ltd
• Nexstim
• Magstim
• Neuronetics
• TMS Neuro Solutions
• MagVenture, Inc.
• eNeura Inc.
• Neurosoft
• MAG & More GmbH
Request for Sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPRE00021783/
Transcranial magnetic stimulator (TMS), also referred to as repetitive transcranial magnetic stimulator (rTMS), is a type of brain stimulation in which a changing magnetic field is applied to a specific area of the brain. An electromagnetic coil is placed against patient’s scalp near forehead during the rTMS session. It is a noninvasive procedure used for diagnostic and therapeutic applications.
The COVID-19 pandemic has broadly interrupted biomedical treatment and research, including noninvasive brain stimulation (NIBS). Moreover, the rapid onset of societal disruption and evolving regulatory restrictions may not have allowed for systematic planning of how clinical and research work may continue throughout the pandemic or be restarted as restrictions are abated. During NIBS procedures, it is often impossible to maintain the recommended physical distance, at least for some time. For instance, applying electrodes for tES or adjusting the position of TMS coils requires direct contact between the person using NIBS and the person receiving NIBS. Moreover, the companies operating in the TMS market have faced a massive loss due to the COVID-19 pandemic. For instance, according to a second-quarter report of Brainsway Ltd., total revenue for the second quarter of 2020 is $4.8 million, which is deceased by 15% as the revenue for the second quarter of 2019 was $5.7 million.
US Transcranial Magnetic Stimulator (TMS) – Market Segmentation
By Type
• Single or Paired Pulse TMS
• Repetitive TMS (rTMS)
By Age Group
• Adults
• Children
By Application
• Research
• Diagnostic
• Therapeutic
Buy Complete Report at: https://www.theinsightpartners.com/buy/TIPRE00021783/
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US Transcranial Magnetic Stimulator (TMS) Market Competition by Company, Country, Application/Type & Forecast to 2028 | MAG & More GmbH, MAG & More GmbH here
News-ID: 2300716 • Views: …
More Releases from The Insight Partners
Armor Materials Market Demand, Share & Growth by 2034
Armor materials are specialized substances designed to protect individuals and assets from various forms of threats, including ballistic impacts, blasts, and other hazardous conditions. These materials are utilized in a wide range of applications, including personal protective equipment, military vehicles, aerospace components, and civil infrastructure. The demand for advanced armor solutions is driven by the need for enhanced safety and security in both military and civilian contexts.
To Get Sample Copy…
Plant based Foods Market Size is Expected to Reach US$ 112.98 Billion by 2034 fr …
The Plant based Foods Market is poised for remarkable growth, driven by increasing consumer awareness regarding health, sustainability, and ethical food choices. According to the latest market research by The Insight Partners, the Plant based Foods Market is projected to grow from US$ 50.40 Billion in 2025 to US$ 112.98 Billion by 2034, registering a CAGR of 9.38% during the forecast period from 2026 to 2034. The rising popularity of…
Multivitamin Tablets and Capsules Market to Reach US$ 49.37 Billion by 2034 at a …
The multivitamin tablets and capsules market is witnessing consistent growth, driven by rising consumer awareness regarding preventive healthcare, increasing demand for dietary supplements, and expanding health and wellness trends across developed and emerging economies. According to The Insight Partners, the global multivitamin tablets and capsules market size is projected to grow from US$ 34.99 billion in 2025 to US$ 49.37 billion by 2034, registering a CAGR of 3.90% during the…
Global Green (Vegetative) Roofing Market Worth US$ 12.46 Billion by 2034, Growin …
The global Green (Vegetative) Roofing Market is poised for remarkable growth as sustainability initiatives, urban greening programs, and energy-efficient construction practices continue to gain momentum worldwide. According to the latest market analysis by The Insight Partners, the market is expected to grow from US$ 3.14 billion in 2025 to US$ 12.46 billion by 2034, registering a robust CAGR of 16.54% during the forecast period of 2026-2034.
Get Sample Copy of Report…
More Releases for TMS
Fast Forward TMS Expands Transportation Management Platform with Broker TMS Soft …
Fast Forward TMS is expanding its transportation management platform with Broker TMS Software, a cloud-based solution designed to help freight brokers, third-party logistics (3PL) providers, and hybrid transportation companies streamline brokerage operations through connected workflows, automation, and improved visibility.
Freight brokerages today face challenges, including increasing shipment volumes, carrier networks, rising costs, and the need for communication. Many businesses still rely on spreadsheets, processes, and disconnected systems that create delays and…
Neuralia TMS Delivers Advanced TMS Therapy for OCD Treatment
Australia, 17th Mar 2026 - Neuralia TMS, a leader in non-invasive neurological treatments, has announced an expansion of its services to include transcranial Direct Current Stimulation (tDCS), an at-home neuromodulation therapy, as well as pharmacogenetic testing to optimise treatment outcomes. Known for its expertise in Transcranial Magnetic Stimulation (TMS) therapy, Neuralia TMS continues to provide evidence-based, drug-free treatments for individuals experiencing conditions such as depression, anxiety, PTSD, obsessive-compulsive disorder (OCD),…
Neuralia TMS Broadens Access to Non-Invasive TMS Treatment for Depression
Australia, 27th Jan 2026 - Neuralia TMS, a respected provider of non-invasive neuromodulation therapies, has announced an expansion of access to Transcranial Magnetic Stimulation treatment for individuals living with depression, reflecting continued developments in evidence-based mental health care and increasing demand for non-pharmacological treatment options. The expanded availability is intended to support patients seeking additional clinical pathways under medical supervision.
Transcranial Magnetic Stimulation, commonly known as TMS, is a non-invasive procedure…
Neuralia TMS Broadens Access to Non-Invasive TMS Treatment for Depression
Australia, 27th Jan 2026 - Neuralia TMS, a respected provider of non-invasive neuromodulation therapies, has announced an expansion of access to Transcranial Magnetic Stimulation treatment for individuals living with depression, reflecting continued developments in evidence-based mental health care and increasing demand for non-pharmacological treatment options. The expanded availability is intended to support patients seeking additional clinical pathways under medical supervision.
Transcranial Magnetic Stimulation, commonly known as TMS, is a non-invasive procedure…
Neuralia TMS Opens Doors in Melbourne to Meet Rising Demand for TMS Treatment Ac …
Australia, 17th Dec 2025 - Neuralia TMS, a leader in Transcranial Magnetic Stimulation (TMS) therapy, has officially opened a new clinic in Moonee Ponds to address the increasing demand for alternative treatments for mental health and chronic pain. The new facility offers non-invasive TMS therapy to treat conditions such as depression, anxiety, and chronic pain by using magnetic pulses to stimulate specific areas of the brain, providing patients with an…
Neuralia TMS Provides Proven TMS Therapy to Help Manage Depression
Australia, 19th Nov 2025 - Neuralia TMS, a respected provider of neuromodulation treatments in Melbourne's inner north, has reaffirmed its commitment to delivering evidence-supported Transcranial Magnetic Stimulation (TMS) therapy for individuals experiencing treatment-resistant depression. The clinic, located at Suite 102/149-155 Pascoe Vale Rd, Moonee Ponds 3039 VIC, continues to operate as a treatment centre offering structured, non-invasive therapeutic programs grounded in current clinical research.
TMS therapy has become an established component…
